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ABSTRACT Strongly bound, force-generating myosin cross-bridges play an important role as allosteric activators of cardiac
thin ﬁlaments. Sodium vanadate (Vi) is a phosphate analog that inhibits force by preventing cross-bridge transition into force-
producing states. This study characterizes the mechanical state of cross-bridges with bound Vi as a tool to examine the
contribution of cross-bridges to cardiac contractile activation. The Ki of force inhibition by Vi was ;40 mM. Sinusoidal stiffness
was inhibited with Vi, although to a lesser extent than force. We used chord stiffness measurements to monitor Vi-induced
changes in cross-bridge attachment/detachment kinetics at saturating [Ca21]. Vi decreased chord stiffness at the fastest rates
of stretch, whereas at slow rates chord stiffness actually increased. This suggests a shift in cross-bridge population toward low
force states with very slow attachment/detachment kinetics. Low angle x-ray diffraction measurements indicate that with Vi
cross-bridge mass shifted away from thin ﬁlaments, implying decreased cross-bridge/thin ﬁlament interaction. The combined
x-ray and mechanical data suggest at least two cross-bridge populations with Vi; one characteristic of normal cycling cross-
bridges, and a population of weak-binding cross-bridges with bound Vi and slow attachment/detachment kinetics. The Ca21
sensitivity of force (pCa50) and force redevelopment kinetics (kTR) were measured to study the effects of Vi on contractile
activation. When maximal force was inhibited by 40% with Vi pCa50 decreased, but greater force inhibition at higher [Vi] did not
further alter pCa50. In contrast, the Ca
21 sensitivity of kTR was unaffected by Vi. Interestingly, when force was inhibited by Vi kTR
increased at submaximal levels of Ca21-activated force. Additionally, kTR is faster at saturating Ca
21 at [Vi] that inhibit force
by .;70%. The effects of Vi on kTR imply that kTR is determined not only by the intrinsic properties of the cross-bridge cycle,
but also by cross-bridge contribution to thin ﬁlament activation.
INTRODUCTION
In addition to being the molecular motors responsible for
force generation and shortening in cardiac muscle, myosin
cross-bridges contribute to thin ﬁlament activation in the
presence of activating [Ca21]. As such they are an important
component of contractile regulation in cardiac muscle. The
cross-bridge contribution to thin ﬁlament activation occurs
following Ca21 binding to cardiac troponin C (cTnC) and the
subsequent displacement of the troponin-tropomyosin (Tn/Tm)
complex into a position on the thin ﬁlament surface that is
permissive to cross-bridge binding to actin (for review see
Gordon et al. (1)). Cross-bridges that make the transition
from the weak initial attachment to strong binding, force-
generating states contribute to activation by at least two
mechanisms in cardiac muscle. First, strong cross-bridges
either stabilize or displace Tn/Tm further toward the ‘‘open’’
state on the thin ﬁlament surface, resulting in exposure of
additional cross-bridge binding sites on actin (2–4). Second,
strong cross-bridge binding allosterically increases the ap-
parent afﬁnity of Tn for Ca21. The latter is evidenced by a
reduction in Ca21 binding to cardiac thin ﬁlaments (5,6) and
reduction of Ca21-induced structural changes in ﬂuores-
cently labeled cTnC in skinned cardiac trabeculae (7,8)
following inhibition of force with the phosphate analog
sodium vanadate (Vi). Together these mechanisms constitute
a positive feedback path that contributes to the steepness and
apparent cooperativity of the cardiac force-[Ca21] relation-
ship (9).
Because maximal Ca21-activated force is strongly inhib-
ited by Vi in skinned cardiac muscle, Vi has been an im-
portant tool for isolating the effects of cross-bridges on thin
ﬁlament activation from those of Ca21 binding to TnC.
However, whereas previous studies have used millimolar
concentrations of Vi to maximally inhibit force and strong
cross-bridge binding, intermediate levels of inhibition may
provide important information to further elucidate the mech-
anisms by which strong cross-bridge/thin ﬁlament interac-
tion contributes to cardiac contractile regulation. However,
the effects of Vi on cross-bridge/thin ﬁlament interaction at
intermediate levels of force inhibition have not been charac-
terized. Vi could inhibit force by either altering the properties
of the entire ensemble of cross-bridges or by shifting the
partition of cross-bridge states from strong to weak binding
during Ca21 activation. Therefore, if Vi is used to probe the
contribution of strong cross-bridge binding to cardiac thin
ﬁlament activation at intermediate levels, it is necessary to
characterize its effects not only on force generation, but on
the distribution of cross-bridges between states that bind
weakly or strongly to thin ﬁlaments. The latter is necessary to
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interpret effects of Vi inhibition of cross-bridge binding on
parameters that monitor changes in thin ﬁlament activation,
such as Ca21 sensitivity of force (pCa50) and the rate of iso-
metric force redevelopment (kTR). In this study we charac-
terized cross-bridge properties at intermediate levels of force
inhibition by Vi using mechanical measurements of force
and stiffness, as well as low angle x-ray diffraction to moni-
tor corresponding changes in cross-bridge mass distribution
between thick and thin ﬁlaments. We further used Vi to study
the mechanisms by which cross-bridge binding determines
both pCa50 and the activation dependence of kTR in skinned
trabeculae from rats.
Increasing [Vi] inhibited force and sinusoidal stiffness,
with force being inhibited to a greater degree than stiffness.
Chord stiffness was used to characterize the kinetics of thick-
thin ﬁlament interaction. The data indicate Vi binding to
cardiac myosin inhibits force by increasing a population of
weak-binding cross-bridges that exhibit slowed attachment/
detachment kinetics. Surprisingly, Vi increased kTR at sub-
maximal Ca21 activation, and at saturating [Ca21] when
force was inhibited by .70%. Taken together the results
indicate that Vi inhibits force by partitioning cross-bridges
between weak-binding cross-bridge states and those with
normal cycling kinetics. Furthermore elevation of kTR at sub-
maximal and maximal forces suggests that kTR reﬂects not
only the intrinsic kinetics of the actomyosin interaction but
also the interaction of cross-bridges with the thin ﬁlament
regulatory apparatus. Preliminary reports of this work have
been published previously (10).
METHODS
Preparation
Male Sprague-Dawley rats (150–250 gram) were anesthetized with an intra-
peritoneal injection of pentobarbital (50 mg/kg). Animals were housed in the
Department of Comparative Medicine and all procedures were done in
accordance with the rules and procedures of the University of Washington
Animal Care Committee. Their hearts are rapidly dissected and placed in
oxygenated physiological salt solution. Trabeculae (1606 10 mm diameter,
1.46 0.1 mm length) were dissected from the right ventricle and chemically
skinned by exposure to a bathing solution containing (in mM): 100 KCl, 9.0
MgCl2, 4.0 MgATP, 5.0 K2EGTA (ethylene glycol-bis-(b-aminoethylether)-
N,N,N9,N9-tetraacetic acid), 10 MOPS (3-(n-morpholino) propane sulfonic
acid), 1% nonionic detergent Triton X-100, pH 7.0, and 50% v/v glycerol for
at least 30 min at room temperature. The skinned trabeculae were stored in
the same solution without Triton X-100 at 20C and used for experiments
within 1 week. Experimental temperature was 15C. Ionic strength was
170 mM.
Solutions
Solution composition was determined according to an iterative computer
program that calculates the equilibrium concentration of ligands and ions
based on published afﬁnity constants. Proprionate was the major anion.
Relaxing solutions contained (in mM): 80 MOPS, 15 EGTA; 1 Mg21;
5 MgATP; 52 Na1; 83 K1; 15 creatine phosphate (CP); and 20 units/ml
creatine phosphokinase (CPK), pH 7.0. Rigor solutions contained no
MgATP, CP, or CPK. For activation solutions, the Ca21 level (expressed as
pCa¼log [Ca21]) was set by adjusting Ca(propionate)2. Sodium vanadate
stock (100 mM) was prepared as described by Goodno (11). Inorganic
phosphate (Pi) was elevated by adding Na2HPO4 to bathing solutions.
Solutions containing elevated MgADP had no CPK or CP, but contained
10 mM ATP along with a myokinase inhibitor (AP5A; Sigma/Aldrich
Chemical, St. Louis, MO) to minimize enzymatic breakdown of added ADP.
Mechanical apparatus
Trabeculae ends were wrapped in aluminum foil T-clips for attachment to a
force transducer (model AE801, $5-kHz resonant frequency [SensoNor])
and a servo-motor (model 300, Cambridge Technology, Lexington, MA)
tuned for a 300-ms step response. Trabeculae were placed in a 200-mL
temperature controlled well. Sarcomere length (SL) was measured with
helium-neon laser diffraction and set at either 2.3 or 2.0 mm in relaxing
solution (pCa 9.0). A detailed description of our mechanical apparatus can
be found in Martyn and Chase (12). Chord stiffness was determined using
stretches of 0.5% muscle length (ML) at varying rates and monitoring the
resulting increase of force during the stretches (13). Stiffness was measured
as the ratio of dF/dt to dML/dt during the period of stretch. During chord
K measurements data were ﬁltered to prevent frequency aliasing and acquired
at rate that was dependent on the rate of stretch and digitized at 12-bit
resolution for analysis with customer software. Sinusoidal stiffness was
determined by sinusoidal length oscillations (60.15 %ML) at 500 Hz. The
baseline for isometric force was measured by transiently shortening the ﬁber
to slack length; relaxed passive force was subtracted from active force. The
rate of force redevelopment (kTR) was measured following a ramp release
(4 ML/s; 15 %ML) followed by a rapid (,350 ms) restretch to the initial
length, as described in Adhikari et al. (14); kTR was determined from the
half-time of force redevelopment as described by Chase et al. (13).
X-ray experiments
Low angle x-ray diffraction measurements were done with single skinned
trabeculae at beamline X27C, National Synchrotron Light Source, Brookhaven
National Laboratories, Upton, NY. The beamline characteristics and ap-
paratus are described in Xu et al. (15) and in Martyn et al. (16). Brieﬂy,
chemically skinned right ventricular trabeculae were placed in an upright
chamber in which solutions can be exchanged and the preparation exposed
to a high intensity synchotron x-ray source. The chamber volume was 0.5 ml
and solutions were continuously stirred with a perfusion pump. To minimize
preparation damage due to x-ray exposure the entire chamber was translated
along the ﬁber axis so that most of the length of the trabeculae was inter-
rogated by the beam. Total exposure time was limited to 4 min for each
preparation. Equatorial intensity from both sides of the meridian of the
equatorial x-ray pattern was summed and the (1,1) and (1,0) intensity pro-
ﬁles were scanned and integrated. Integrated intensities and spacings of the
equatorial 1,0 and 1,1 diffraction peaks were determined using PeakFit
(SPSS, Chicago, IL).
Data analysis
Force-pCa data were ﬁt by the Hill equation,
F ¼ Fmax= 11 10nHðpCa50pCaÞ
 
where Fmax is the maximally activated force, nH is the Hill coefﬁcient or
slope, and pCa50 is the pCa at which force is half-maximal. The reported
pCa50 and nH values represent the means of the values from the individual
ﬁts, mean6 SE. Means are compared with Student’s t-test with signiﬁcance
at the 95% conﬁdence level (P , 0.05). Statistical analysis was performed
using Excel (Microsoft, Redmond, WA), SigmaPlot (Systat, Richmond,
CA), and PeakFit (SPSS).
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RESULTS
The effect of [Vi] on maximal Ca21-activated isometric
force in rat single skinned trabeculae was determined by the
protocol described in Fig. 1. Initial sarcomere length was
2.3 mm. First, the ﬁber was transferred from a relaxing solu-
tion (pCa 9.0) to preactivating solution with low [EGTA]
(0.1 mM), followed by maximal activating solution (pCa
4.5) and then pCa 4.5 solution with Vi added. This protocol
was used because exposure of the ﬁber to Vi in relaxing
solution before Ca21 activation for any length of time up to
30 min did not inhibit force. Force was only inhibited if the
preparation was exposed to Vi during Ca21 activation, as
shown for skeletal ﬁbers (17,18). Following exposure to pCa
4.5 plus Vi, the ﬁber was relaxed and the sarcomere length
readjusted to 2.3 mm, if necessary. This was followed by
placing the trabecula in a series of solutions containing
increasing [Ca21] to allow determination of the force-pCa
relation, with 0.3 mM Vi added to each solution. The ﬁber
was then washed in relaxing solution with no Vi and allowed
to develop force at pCa 4.5 with no Vi. Recovery from Vi
inhibition was 79 6 3% (n ¼ 5). The ﬁnal rise of force took
signiﬁcantly longer than the rise of force during the initial
activation without Vi, as we have previously observed for
skinned skeletal ﬁbers (18). In each solution, sinusoidal
stiffness, kTR and chord stiffness were measured. The maxi-
mal Ca21-activated force at 2.0 mm SL for all preparations
was 29.8 6 5.6 mN/mm2 (n ¼ 10). The effects of Vi on
stiffness were assessed at 2.0 mm SL because at this length
passive force and its contribution to the sinusoidal and
chord-stiffness measurements were minimal. Qualitatively
similar stiffness data were obtained at 2.3 mm SL in all cases
(data not shown).
Care must be taken to limit the [Vi] used to inhibit force
because exposure of skinned cardiac muscle to high con-
centrations of Vi (10 mM) has been shown to extract whole
troponin, causing Ca21-insensitive active force (19). How-
ever it is unlikely that troponin was extracted from the prep-
arations used in this study because resting force (pCa 9.2)
after Vi treatment and following recovery from force in-
hibition, was completely unaffected by Vi concentrations
from 0.05 to 1.0 mM, as shown in Fig. 1 (0.3 mM Vi.).
The effects of force inhibition by Vi on force,
sinusoidal stiffness, and kTR at saturating [Ca
21]
Examples of force traces obtained during kTR measurements
are shown in Fig. 2 at pCa 4.5, in the absence and presence of
1.0 mM Vi, and following recovery from inhibition. The
steady-state force was reduced to 23% of control with
inhibition and recovered to 79% following washout of Vi. In
Fig. 2 force is normalized to the maximum for each condition
to emphasize differences in force redevelopment kinetics
(the inset shows the original force traces). Interestingly, kTR
was faster in the presence of 1.0 mM Vi compared to control
solutions.
The effect of [Vi] on maximal Ca21-activated force
(Fmax), sinusoidal stiffness, and kTR are illustrated in Fig. 3
A. The data are normalized to values obtained in the absence
of Vi for each condition. Fmax was inhibited with increasing
[Vi] (Ki of ;40 mM) at both 2.0 and 2.3 mm SL. Sinusoidal
stiffness also decreased with increasing [Vi], (Kd¼;60mM),
but to a lesser extent than force. This apparent difference in
the sensitivity of force and stiffness to Vi is emphasized in
Fig. 3 B, where the ratio of stiffness/force increases sub-
stantially at higher [Vi] and lower force. In contrast to force
and stiffness, at intermediate [Vi] (0.02–0.3 mM) maximal
kTR was not signiﬁcantly different from controls. However,
at higher [Vi] (1.0 mM) force was only 17 6 2.0% (n ¼ 5
trabeculae) of control, while kTR increased from 21.56 2.7 s
1
to 24.6 6 2.8 s1 (P , 0.05). Combined, these data suggest
that Vi decreased cross-bridge binding, but that cross-bridge
cycling rates (kTR) may be unaffected or increased at satu-
rating [Ca21].
FIGURE 1 Force was maximally activated at pCa 4.5. After steady-state
force was reached, force was inhibited with 0.3 mM Vi, followed by re-
laxation in pCa 9.2. Force was subsequently measured at various submax-
imal [Ca21] (indicated below the force trace), each with 0.3 mM Vi. The
trabeculae was again relaxed. The relaxed trabecula was ﬁnally activated in
pCa 4.5 to allow force recovery (typically .80%). Initial sarcomere length
was 2.3 mm and diameter was 125 mM. The calibration bars represent 30 mg
(vertical) and 1 min (horizontal).
FIGURE 2 Representative traces of force redevelopment following the
rapid release/restretch protocol used to determine kTR are shown; kTR was
determined during steady force at each [Ca21] and [Vi]. Force was nor-
malized to the maximum for each condition and is shown for preinhibition
controls, following force inhibition by 1.0 mM Vi and subsequent to force
recovery from Vi inhibition. The time course of force development in
controls and following recovery from inhibition nearly superimpose. The
corresponding unnormalized traces are shown in the inset; kTR was 15.9 s
1
in pC 4.5 controls, 23 s1 with 1.0 mM Vi and 14.9 s1 following recovery
from inhibition in pCa 4.5.
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The effect of increasing [Vi] on chord stiffness
Measurements of chord stiffness have been used to charac-
terize the attachment/detachment kinetics of the acto-myosin
interaction in skinned skeletal ﬁbers (20,21). To determine if
Vi alters katt/kdet we compared the chord stiffness of skinned
cardiac trabeculae during maximal Ca21 activation (pCa
4.5), without and with Vi, as described in Fig. 4. Trabeculae
were stretched (0.15 %ML) at varying rates from 0.1 to
1500 %ML s1. Chord stiffness was obtained in rigor to
determine the maximum stiffness and stretch rate dependence
of stiffness for strongly bound, noncycling cross-bridges
(solid circles). Vi decreased chord stiffness compared to
control (open circle; pCa 4.5 without Vi) at stretch rates
above ;10 %ML s1. Below this rate chord stiffness
increased slightly relative to control (Fig. 4 A). To illustrate
the differing sensitivity of chord stiffness to Vi at low and
high stretch rates the data in panel A were normalized to the
maximum stiffness at high stretch rates at each [Vi] in Fig. 4
B. This emphasizes a peak or plateau in chord stiffness at
slower stretch rates, that becomes more prominent as the
[Vi] increases and the absolute magnitude of chord stiffness
at high stretch rates decreases. Above 10 %ML s1 the
normalized stiffness-stretch rate dependence at all [Vi] was
not different from maximally activated controls (no Vi). The
dependence of chord stiffness on stretch rate is thought to be
determined primarily by the apparent cross-bridge detach-
ment rate (kdet) (Brenner (20); Schoenberg (46)). Thus the
shift of the stiffness-stretch rate proﬁle in Fig. 4 B toward
slower rates implies decreased kdet for a population of cross-
bridges with bound Vi and could be consistent with the
apparent slow Vi dissociation rate evidenced by prolonged
force recovery (Fig. 1). Although decreased stiffness at high
stretch rates with Vi implies decreased cross-bridge/thin
ﬁlament interaction, the data at low rates indicate that a sig-
niﬁcant fraction of cross-bridges with bound Vi might still
interact with thin ﬁlaments, albeit in weak-binding states that
contributed little to force and stiffness.
To determine if this was the case, we used low angle x-ray
diffraction of activated skinned trabeculae to characterize Vi
effects on cross-bridge/thin ﬁlament interaction more di-
rectly. Changes in the ratio of the 1,1 and 1,0 equatorial
reﬂection intensities (I1,1/I1,0) during Ca
21 activation were
measured in the presence (1.0 mM) and absence of Vi.
Although it was not possible to measure force with our x-ray
apparatus, data were obtained with exactly the same solutions
FIGURE 3 The dependence of force
on [Vi] with maximal activating [Ca21]
(pCa 4.5) at SL ¼ 2.3 (d) and 2.0 (s)
mm, along with sinusoidal stiffness (n)
at 2.0 mm initial SL, is illustrated in A.
Also shown in A is the dependence of
the maximal rate of isometric force re-
development (kTR;;) on [Vi] at SL ¼
2.0 mm. At pCa 4.5 with 1.0 mM Vi,
kTR (;*) was signiﬁcantly faster than
control (P , 0.05). All variables in
panel A have been normalized to the
corresponding values obtained at pCa
4.5 without Vi; data were obtained from
seven trabeculae. The force and stiff-
ness data in A are replotted in B to
illustrate Vi effects on the stiffness/
force ratio at pCa 4.5 and 2.0 mm SL.
FIGURE 4 Skinned trabeculae were
stretched at constant amplitude (0.5
%ML) at varying rates and the resulting
changes in stiffness were measured at
various [Vi], as indicated in the inset.
In A the results were compared to maxi-
mum Ca21 activation (no Vi; s) and
rigor (d). Vi reduced stiffness at all
rates of stretch above ;10 %ML s1,
whereas below this rate stiffness in-
creased. In A data are normalized to the
maximum stiffness at high stretch rates
in uninhibited controls. Chord stiffness
in B is expressed relative to the maxi-
mum stiffness value at high rates of stretch for each [Vi]. The data in B emphasize the peak in chord stiffness at slower rates of stretch, implying the presence
of a cross-bridge population with slowed attachment/detachment kinetics. The curves in panels A and B were obtained by nonlinear ﬁtting of the data with
Peak-Fit (SPSS, Chicago, IL).
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and conditions used for force measurements and the
trabeculae were in a small volume (;0.5 ml) chamber for
rapid solution changes (,1 s). Increased or decreased I1,1/I1,0
indicates a corresponding movement of cross-bridge mass
toward or away from thin ﬁlaments, respectively. Trabeculae
were maximally activated and then exposed to pCa 4.5 with
1.0 mM Vi and relaxed. Vi treated preparations were
subsequently exposed to increasing [Ca21] in the presence of
1.0 mM Vi. The [Ca21] dependence of I1,1/I1,0 in controls
and Vi treated trabeculae is shown in Fig. 5 A, along with
corresponding changes in myoﬁlament lattice spacing (D1,0)
in Fig. 5 B. Without Vi (solid circle) I1,1/I1,0 increased nearly
fourfold (n ¼ 5 trabeculae) over the pCa range where force
increased (see Fig. 8 A). In contrast, whereas I1,1/I1,0 was
increased slightly (from 0.35 6 0.02 to 0.42 6 0.03; P ,
0.05) from pCa 6.0 to pCa 4.5 with 1.0 mM Vi (open circle;
n ¼ 4 trabeculae)), it was greatly reduced compared to
control over the same pCa range. Vi had no effect on the
relaxed (pCa 9.2) equatorial ratio.
Interestingly, lattice spacing (D1,0; Fig. 5 B) decreased
with increasing [Ca21] in the absence of Vi, as observed in
skinned skeletal ﬁbers (22,23), whereas with Vi increasing
[Ca21] had no signiﬁcant effect on D1,0 (Fig. 5 B). The
observation that D1,0 decreased during Ca
21 activation of
skinned cardiac muscle is important and indicates that initial
relaxed lattice spacing may not be an accurate indicator of
the spacing achieved during active contraction. Taken to-
gether these data show that force inhibition by Vi was as-
sociated with cross-bridge mass movement away from thin
ﬁlaments and toward thick ﬁlaments, indicating decreased
cross-bridge/thin ﬁlament interaction. Similar Vi effects on
thick ﬁlament structure have been observed in frog skinned
skeletal ﬁbers (24).
Effects of ADP and Pi on force, kTR, and
stiffness at maximal Ca21 activation
To support the idea that stiffness elevation at slow stretch
rates with Vi reﬂected slowed katt/kdet (Fig. 4), we measured
chord stiffness when actomyosin cycle kinetics were altered
by means other than Vi. To decrease cross-bridge cycling
kinetics 0.1, 1.0, or 5 mM ADP was added to pCa 4.5
activating solutions (25,26), whereas increased [Pi] (30 mM)
was used to increase cross-bridge kinetics, as shown for both
skinned skeletal (27) and cardiac preparations (28,29). Addi-
tion of up to 5.0 mM ADP to bathing solutions increased
Fmax and sinusoidal stiffness by ;20%, and greatly reduced
kTR, as shown in Fig. 6. Similar effects of elevated [ADP] on
force and kTR were obtained in skinned skeletal ﬁbers
(25,30–33). Slowing of kTR by ADP has been attributed to
reduction of kdet (33–36); 30 mM Pi inhibited Fmax and
maximal sinusoidal stiffness to 0.476 0.15 and 0.496 0.16
(n ¼ 3 trabeculae) of control (no added Pi), respectively.
Chord stiffness versus stretch rate relations demonstrated
that Vi (Fig. 4) acts on cross-bridge kinetics differently than
does increased [ADP] or 30 mM Pi (Fig. 7, A and B,
respectively). Data in Fig. 7 are expressed as a fraction of
maximum obtained in each condition at the highest stretch
rate and were obtained at 2.0 mm initial SL. In Fig. 7 A
increasing [ADP] increased stiffness at stretch rates between
10 and 100 %ML s1, creating a plateau in the stiffness
versus stretch rate relation when [ADP] was 5.0 mM. This
range for elevated stiffness was ;10–100 times faster than
following Vi inhibition of force (Fig. 4). This cannot be
attributed to rigor cross-bridges, as the activation solutions
all contained 10 mM ATP (see Methods). The data in Fig. 7
indicate that with Vi enhancement of stiffness at very slow
stretch rates (Fig. 4) likely indicates the presence of a process
with signiﬁcantly slower attachment-detachment kinetics
than found in the presence of ADP. Importantly, 30 mM Pi
shifted the entire chord-stiffness curve (Fig. 7 B) toward
higher stretch rates and faster kinetics compared to controls
(no added Pi). This is different than the effect of Vi (Fig. 4)
and strongly suggests that Vi does not act as a functional Pi
analog in terms of mechanical properties of cross-bridges.
Effect of Vi on the Ca21-activation dependence
of kTR
The Ca21 dependence of force and kTR at various [Vi] are
shown in Fig. 8 A and B, respectively. Data (means 6 SE)
were normalized to Fmax or maximal kTR in controls with no
Vi. Force in Fig. 8 A was ﬁt with the Hill equation and
the pCa50 and slope (nH) for each condition are included in
FIGURE 5 The equatorial x-ray re-
ﬂection intensity ratio (I1,1/I1,0; Fig. 5
A) and myoﬁlament lattice spacing (D1,0;
Fig. 5 B) was determined at various
[Ca21] from pCa 9.2 to 4.5 in the
absence (solid symbols; n ¼ 6 trabec-
ulae) and presence (open symbols; n ¼
4 trabeculae) of 1.0 mM Vi. I1,1/I1,0 (A)
and D1,0 (B) for rigor conditions (n;
n ¼ 4) are included for comparison.
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Table 1. While Fig. 3 and Table 1 both contain similar data
describing the effect of Vi on Fmax, the results in each were
acquired from different sets of trabeculae. Inhibition by Vi to
60% of Fmax decreased pCa50 and had no signiﬁcant effect
on nH. Greater levels of force inhibition did not further
decrease pCa50 or alter nH (Table 1). Like force, kTR was
Ca21 dependent (Fig. 8 B). Over the range of [Ca21] where
kTR was measured in the presence of Vi, inhibition of force
had little effect on the Ca21 sensitivity of kTR. However, it
should be noted that at higher [Vi] and greater force in-
hibition, it was difﬁcult to obtain reliable kTR values at low
[Ca21] and very low forces. For this reason only the control
kTR-pCa data were ﬁt with the Hill equation in Fig. 8 B.
To illustrate the effect of Vi on the apparent thin ﬁlament
activation level (force) the data in Fig. 8 were replotted in
Fig. 9 as kTR versus force for varying [Vi]. Force is expressed
relative to Fmax in the absence of Vi. At equivalent sub-
maximal force levels, Vi increased kTR. However, similar force
(to control) in the presence of Vi was obtained at higher levels
of Ca21, obscuring whether kTR was dependent more on Ca
21
or force level. To assist interpretation of the data the dashed
lines in Fig. 9 indicate data obtained at the same [Ca21].
This demonstrates that at the same submaximal [Ca21], kTR
increased when [Vi] was $0.3 mM and force was inhibited
below 60% Fmax. The elevation of kTR at a constant [Ca
21]
when force is inhibited by Vi, suggests that the rate of force
development is not a simple function of either Ca21 or the
number of strongly binding cross-bridges in cardiac muscle.
This will be discussed below in detail.
DISCUSSION
We characterized the effects of force inhibition by Vi on
cross-bridge binding to thin ﬁlaments and on force redevel-
opment kinetics (kTR) in skinned cardiac trabeculae from
rats. Vi inhibited force to a greater extent than sinusoidal
stiffness (Fig. 2), often used as an indicator of the number of
strongly bound cross-bridges, and had a complex effect on
the apparent attachment-detachment kinetics of cross-
bridges, as determined with chord-stiffness measurements
(Fig. 4). Chord-stiffness measurements in conjunction with
data from x-ray diffraction (Fig. 5) indicate that at interme-
diate levels Vi inhibits force by establishing a separate
population of weak-binding cross-bridges with very slow
kinetics, while leaving a population of normal cycling cross-
bridges. Other signiﬁcant ﬁndings of this study were that
whereas Vi inhibited maximal force (Fmax) and stiffness,
maximal kTR actually increased at higher [Vi] (Figs. 3 A and
9). Furthermore, at submaximal Ca21 activation Vi increased
kTR (Fig. 9), opposite of what might be expected if kTR were
dependent only on the level of steady-state force or [Ca21].
These results are discussed in the context of the effects of
Vi on: 1), the partition of cross-bridges between states that
interact weakly or strongly with thin ﬁlaments (Fig. 4); 2),
the effects of inhibiting strong cross-bridges on the Ca21 sen-
sitivity of force and kTR (Fig. 8); and ﬁnally, 3), mechanisms
whereby Vi increased the rate of cross-bridge transition from
weak- to strong-binding, force-producing states ((kTR; Fig. 9).
FIGURE 6 The effects 0.1, 1.0, and 5.0 mM ADP on maximum Ca21-
activated force (black bars), kTR (light gray bar), and sinusoidal stiffness
(dark gray bar) are illustrated. Data were obtained from six trabeculae.
Values are expressed relative to those obtained with no added ADP.
FIGURE 7 The inﬂuence of increas-
ing [ADP] and 30 mM Pi on chord
stiffness measurements is illustrated in
panels A and B, respectively. Data were
obtained from six trabeculae in A and
three trabeculae inB. In panelAdatawere
obtained at pCa 4.5 with 0.1 mM (s;
heavy dashed line), 1.0 mM (;; dotted
line) and 5.0 mM (n; dashed-dot-dot)
ADP. Respective control measurements
with noADPor Pi added to solutions are
shown inA andB (d; solid lines). Chord
stiffness at each rate of stretch is nor-
malized to themaximal level of stiffness
at high rates of stretch for each condi-
tion. Initial SL was 2.0 mm.
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Effects of Vi on cross-bridge binding to cardiac
thin ﬁlaments
Vi is a phosphate analog that binds to the myosin-S1 head
and inhibits acto-myosin ATPase (37) and force (17). The
M.ADP.Vi complex is an analog of the posthydrolysis
M.ADP.Pi state that binds weakly to actin (17). Cross-
bridges with bound Vi appear to be in the ‘‘closed’’ struc-
tural conformation (38,39) correlated with a posthydrolysis
or preforce state (40,41). Vi dissociates slowly from either
M.ADP.Vi or from A.M.ADP.Vi, as evidenced by: 1), an
apparent lack of force recovery following prolonged expo-
sure of Vi-treated ﬁbers or trabeculae to relaxing solution
without Vi; and 2), the slow force recovery when Vi-treated
skeletal (17,18) or skinned cardiac trabeculae (Fig. 1) are
exposed to activating Ca21. The apparent slow dissociation
of Vi, compared to Pi, prevents or greatly slows cross-bridge
transition into force generating states. Thus, although Vi is a
phosphate analog, its slow dissociation from myosin con-
trasts with the rapid kinetics of Pi exchange (42).
Our observation that sinusoidal stiffness was inhibited to a
lesser extent than force by Vi (Fig. 2, A and B), indicates that
the cross-bridge population shifts toward states that bind
weakly (no force), but strongly enough to contribute to ﬁber
stiffness (27). However, this interpretation of stiffness data
must be tempered by at least two considerations. First,
skinned cardiac trabeculae have unavoidable compliances
from damage to the ends where T-clips are fastened and
second, myoﬁlament compliance can lead to an overestima-
tion of ﬁber stiffness, particularly at low forces (43,44). On
the other hand, the chord stiffness data in Fig. 4 appear to
support the idea that in the presence of Vi during Ca21
activation the cross-bridge population shifts away from
active cycling toward stably bound states that have slow
attachment/detachment kinetics and interact weakly with
thin ﬁlaments. This idea is further supported by our ob-
servation that the equatorial x-ray reﬂection ratio (I1,1/I1,0;
Fig. 5 A) is signiﬁcantly reduced at maximal activating
[Ca21] by 1.0 mM Vi, indicating a reduction of both strong
and weak cross-bridge/thin ﬁlament interaction.
Chord stiffness: implications for cross-bridge
binding and kinetics
The relationship between chord stiffness and the rate of ﬁber
stretch is sensitive to changes in attachment-detachment
kinetics, with the overall kinetics being dominated by kdet
(katt  kdet) (20,45,46). This analysis assumes the katt con-
trols the initial diffusion limited formation of the A.M.ATP
or A.M.ADP.Pi collision complex and is thus fast. During a
constant amplitude stretch at a given rate, the amount of
stiffness measured will be directly determined by the fraction
of time cross-bridges are bound to actin (katt/(katt 1 kdet)). In
the absence of Ca21 weak, nonforce-producing cross-bridges
bind to thin ﬁlaments with very fast kinetics and stiffness is
FIGURE 8 The Ca21 dependence of
force (A) and kTR (B) are shown at
different [Vi]. Force in panel A and kTR
in panel B are normalized to the max-
imum for each condition. Data were
pooled from ﬁbers that produced;60%
(s; dashed line), ;40% (;; dashed-
dot line), and;20% (,; dotted line) of
maximum Ca21-activated force in con-
trol ﬁbers. The force data in panel A
were ﬁt with the Hill equation and
pCa50 and nH are included in Table 1,
along with corresponding values of Fmax
and maximal kTR. The Hill ﬁt parameters
for control kTR-pCa data in panel B
were 5.62 6 0.01 and 3.0 6 0.14, for






(mM) (mN/mm2) %F*max 6SE nH 6SE pCa50 6SE (s
1) %kTRmax* 6SE
0.00 10 29.8 5.6 1.00 0.00 5.5 0.6 5.62 0.03 21.7z 1.7 1.00 0.00
0.05 6 15.7 3.1 0.66 0.02 7.2 1.1 5.52 0.01 19.5 2.2 0.91 0.10
0.10 7 9.8 2.0 0.40 0.03 5.0 0.2 5.52 0.03 18.7 2.1 1.03 0.10
0.30 6 8.4 2.2 0.20 0.02 4.9 0.9 5.48 0.03 18.9 3.0 1.14 0.08
*% Fmax and %kTRmax are taken as a percent of the control value within the same trabeculae.
ykTR at pCa 4.5 for each condition.
zMean value for all trabeculae.
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only generated at rapid rates of stretch (21). In contrast, if kdet
is decreased relative to katt, as would occur during active
contraction, cross-bridges will interact longer with actin
during the stretch, leading to increased cross-bridge strain
and shifting the stiffness versus stretch rate relation toward
slower stretch rates, as seen with elevated [ADP] (Fig. 7).
Force inhibition by Vi had a complex effect on the
stiffness-stretch rate relationship (Fig. 4, A and B). Increasing
[Vi] inhibited stiffness at stretch rates above 10 %ML s1,
indicating a shift of cross-bridges from strong- to weak-
binding states. In contrast, from 0.1 to 1 %ML s1 stiffness
was slightly increased (compared to controls), causing a
broad elevation that reached a maximum at ;1 %ML s1.
Elevation of chord stiffness at ;1 %ML s1 with increasing
[Vi] (Fig. 4 B) is consistent with an increasing population
of weak-binding (no or low force) cross-bridges in the
AM.ADP.Vi state that are characterized by slow attachment-
detachment kinetics. This contrasts with the effect of ADP or
Pi (which also alters katt/kdet), where chord stiffness increases
over a different range of stretch rates (Fig. 7).
Elevated [ADP] increased Fmax and slowed kTR in cardiac
trabeculae (Fig. 6). In skinned skeletal ﬁbers increased force,
decreased kTR and decreased unloaded shortening velocity
with elevated [ADP] were attributed to a decreased cross-
bridge/detachment rate (33–36). Likewise the enhancement
of chord stiffness at slower stretch rates (Fig. 7 A) is con-
sistent with decreased apparent kdet of active cycling cross-
bridges. For cycling cross-bridges under control conditions
the amount of stiffness measured at the fastest attainable
rates of stretch is limited by the rapid kdet. If this were not
true stiffness should become constant at the highest stretch
rates (20,45,47). Thus, the relative constancy of stiffness
from ;100 to 1500 %ML s1 in Fig. 7 A indicates that
elevated ADP decreased kdet, thereby prolonging strong
cross-bridge binding and maximizing cross-bridge strain at
much lower stretch rates. It should be noted that although
both ADP and Vi elevated stiffness at slow rates of stretch
during maximal Ca21 activation, ADP enhanced strong
cross-bridge binding and force (Fig. 6), whereas Vi de-
creased strong cross-bridge binding and force (Figs. 2 and 4).
Thus, comparison of the chord stiffness data for Vi versus
ADP demonstrates that slowed apparent cross-bridge cycling
rates occur by different mechanisms. With ADP slowing
comes from a buildup of cross-bridges in strongly bound
states (due to reduced kdet), whereas with Vi slowing of
apparent attachment-detachment kinetics is correlated with
reduced numbers of cross-bridges that participate in cross-
bridge cycling and force generation.
In contrast to ADP (Fig. 7 A) the right shift of the chord
stiffness versus stretch rate relation with 30 mM Pi (Fig. 7 B)
is consistent with faster cross-bridge cycling, evidenced by
increased kTR in skeletal (27) and cardiac muscle (29), and
rapid reduction of strong cross-bridge binding by photo-
released Pi in skinned skeletal ﬁbers (48) and cardiac
myocytes (29). Furthermore the entire curve in Fig. 6 was
shifted toward higher stretch rates with elevated Pi, implying
that apparent kdet increased in the majority of the cycling
cross-bridge population. These observations are consistent
with the idea that Pi exchange on myosin is rapid (42), unlike
Vi. Furthermore, the shift in the stiffness/rate proﬁle to faster
rates with increased [Pi] (Fig. 7 B) contrasts sharply with the
corresponding effects of Vi (Fig. 4), a phosphate analog.
Thus, unlike Vi, there is no evidence for Pi partitioning
cross-bridges into noncycling and cyling populations.
Although speculative, the following simple schematic pro-
vides a framework within which the effects of Vi on steady-
state force and stiffness in cardiac muscle can be interpreted:
Step 1 indicates initial cross-bridge binding in the ‘‘weak’’
state that is obligatory (49) for cross-bridge isomerization
into force generating states in the presence of Ca21 (step 2).
The kinetics of step 1 are thought to be rapid, as indicated by
increasing chord stiffness at high rates of stretch in relaxed
skeletal (21) and cardiac muscle (16). When Vi binds to
cross-bridges in activating solutions, there is a transition to a
weak-binding Vi bound state (thick arrow; step 3) that is in
dynamic equilibrium with detachment (step 5). Strong force
inhibition by Vi in the presence of Ca21 (step 3) implies that
the transition of weak cross-bridges with bound Vi to strong
binding is comparatively small (thin arrow; step 3). When Vi
is removed in the presence of Ca21, cross-bridges can slowly
FIGURE 9 The data in Fig. 8 are replotted as kTR versus isometric force
(relative to pCa 4.5 in controls), to emphasize the activation dependence of
kTR in skinned cardiac trabeculae at increasing levels of force inhibition with
Vi. Data obtained at a given [Ca21] is connected by dashed lines, with the
pCa being given at the right.
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exchange Pi for Vi and transition toward strong binding
states, as evidenced by a prolonged recovery of force
(Fig. 1). This could occur in the presence of Ca21 by either
slow exchange of Vi for Pi (step 4) or by slow dissociation of
Vi from AM.ADP.Vi to produce AM.ADP, which transi-
tions directly into strong binding (thin arrow; step 3). In
either case the population of strong binding cross-bridges
increases during recovery from inhibition.
There are two observations that suggest little or no ex-
change of Pi for Vi between the cross-bridge populations
with either Vi or Pi bound (dashed boxes) when Vi is present
in either activating (step 4) or relaxing (step 4 or 6) solutions.
First, exposure of ﬁbers to Vi in relaxing solutions, before
Ca21 activation without Vi, does not inhibit subsequent
Ca21 activation of force. Second, once force is inhibited by
Vi in activating solutions, long exposures to relaxing solu-
tion without Vi does not reverse inhibition (see Fig. 1).
One consequence of this scheme is that with Vi two pop-
ulations of weak-binding cross-bridges may be established,
those with either Pi or Vi bound. The weak-binding cross-
bridges with Pi would cycle with normal rapid attachment/
detachment kinetics and in the presence of Ca21 transition
into strong-binding states, whereas those with bound Vi
would be ‘‘locked’’ into a weak state with slow apparent katt/
kdet. The slow recovery of force in inhibited ﬁbers following
activation without Vi suggests that Vi dissociation from
cross-bridges is slow. If true, detachment of cross-bridges
with bound Vi from actin (kdet) may be slower than cross-
bridges with Pi bound, as indicated by comparison of Figs. 4
and 7 B. The presence of a ‘‘hump’’ in the stiffness-stretch
rate relation (Fig. 4) is consistent with at least two stable
weak binding cross-bridge populations, with little exchange
between them (steps 4 and 6), as long as Vi is present. If
exchange between these two states was rapid one might
expect a shift of the entire curve toward faster stretch rates, as
found for elevated Pi (Fig. 7 B), rather than the appearance of
a distinct peak or plateau at slow stretch rates. Therefore, the
data are consistent with the presence of a distinct population
of weakly binding cross-bridges with slowed attachment/
detachment kinetics, along with a population of normally
cycling cross-bridges, indicated by the similar stretch rate
dependence of stiffness at faster rates of stretch, with and
without Vi (Fig. 4 B). This interpretation is consistent with
observations that whereas elevated Pi inhibits force, but not
unloaded shortening velocity in skinned skeletal ﬁbers (50),
Vi inhibits both (18). This, along with the chord stiffness
data in Fig. 4, implies that cross-bridges with bound Vi in-
teract with thin ﬁlaments long enough to impose an internal
load on shortening.
The effects of Vi on kTR
Force inhibition by Vi was associated with enhanced kTR at
all submaximal force levels (Fig. 8 B), but had little effect on
the Ca21 sensitivity of kTR (Fig. 7 B). A similar enhancement
of contractile kinetics in cardiac muscle was described by
Herzig et al. (51). When Vi inhibited force, force redevel-
opment kinetics following a rapid stretch and the ATPase/
force ratio in cardiac muscle was increased. Maximal kTR in
skeletal muscle is thought to be determined primarily by the
intrinsic rate of acto-myosin cycling (20,52,53). However,
we (54), and others (55), have recently demonstrated that
maximal kTR in cardiac muscle is also dependent on thin
ﬁlament activation state; kTR is Ca
21 dependent in striated
muscle, exhibiting a strong apparent cooperativity when
plotted against force. Signiﬁcant evidence (reviewed in
Gordon et al. (1) and Regnier et al. (54)) suggests this Ca21
regulation occurs via modulation of thin ﬁlament state,
which regulates cross-bridge transitions from weak to strong
binding, force bearing states, and, perhaps, the rate of cross-
bridge detachment (56,57).
The contributions of thin ﬁlament activation by Ca21 and
cross-bridges (weak to strong transitions) to kTR are empha-
sized in Fig. 9. When strong cross-bridge binding and force
were inhibited by Vi kTR was faster at a given level of sub-
maximal force. However, force in Fig. 9 is expressed relative
to maximal (pCa 4.5) in controls (no Vi). Because increasing
[Vi] decreased force at a given [Ca21], a higher [Ca21] was
required to achieve the same relative force. Thus faster kTR
with elevated [Vi] (at the same relative force level; Fig. 9)
was associated with increased [Ca21]. This makes it difﬁ-
cult to distinguish whether kTR was increased by Vi or by
elevated [Ca21] and Ca21 binding to thin ﬁlaments. How-
ever, when data are compared at the same submaximal
[Ca21] (dashed lines; Fig. 9), force inhibition below 60%
Fmax by Vi increased kTR. Thus at a given [Ca
21] elevated
kTR in the presence of Vi was associated with reduced cross-
bridge binding and a decreased cross-bridge population avail-
able for recruitment (Fig. 4). These observations indicate that
kTR dependence on thin ﬁlament activation is determined by
both Ca21 binding to troponin and the availability of cross-
bridges for recruitment to strong-binding states. Furthermore
the increase of kTR at a given submaximal [Ca
21] with
increasing [Vi] (dashed lines; Fig. 9) could be under-
estimated. While bathing [Ca21] was the same, force inhibi-
tion probably decreased the amount of Ca21 bound to thin
ﬁlaments. This is because strong cross-bridge binding has
been shown to enhance Ca21 binding to troponin in cardiac
muscle (5,6). Consequently, at higher [Vi] less Ca21 could
be bound to thin ﬁlaments at the same bathing solution
[Ca21]. This implies that if kTR could be compared at the
same submaximal level of Ca21 binding to troponin, kTR
would increase even more at a given [Vi].
Although our results imply that the apparent activation
dependence of kTR in cardiac muscle reﬂects the effects of
both Ca21 binding and cooperative activation of cardiac thin
ﬁlaments by strongly bound cross-bridges, an alternative
explanation for the effects of Vi on kTR is possible. For
example, elevation of kTR by Vi could be explained if cross-
bridges in the weak-binding AM.ADP.Vi state were capable
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of activating cardiac thin ﬁlaments. If true, cross-bridges
with bound Vi could elevate thin ﬁlament activation similar
to NEM-S1 (55), although NEM-S1 increased the Ca21 sen-
sitivity of force, whereas Vi decreases it (Fig. 7 A; Table 1).
However, several arguments can be made against this ex-
planation. First, the absolute magnitude of the stiffness at
;1 %ML s1 is only ;5% of the maximum stiffness at the
fastest stretches (Fig. 4 A), implying a corresponding propor-
tion of bound cross-bridges in the AM.ADP.Vi state (assum-
ing that cross-bridges in all states have approximately the
same unitary stiffness). The corresponding decrease in
equatorial reﬂection ratio at full Ca21 activation (Fig. 5 A)
is also consistent, in conjunction with chord-stiffness mea-
surements (Fig. 4), with Vi causing a signiﬁcant reduction in
cross-bridge/thin ﬁlament interaction. Thus it is difﬁcult to
imagine how a small population of weak-binding cross-
bridges could cause signiﬁcant thin ﬁlament activation.
Furthermore, if cross-bridges with bound Vi attached to
cardiac thin ﬁlaments in a ‘‘rigor-like’’ state, and were able
to activate thin ﬁlaments, then inspection of the rigor data in
Fig. 4 A suggests that stiffness should be elevated at all
stretch rates, unlike the relative elevation of stiffness at
;1 %ML s1. Finally, Fig. 4 A indicates that the absolute
amplitude of stiffness at all stretch rates decreased above
0.02 mM Vi. If the ‘‘hump’’ in stiffness at low stretch rates
is attributed to cross-bridges in the AM.ADP.Vi state, it is
difﬁcult to attribute an increase of apparent activation at
higher [Vi] (elevated submaximal kTR; Fig. 9) to a decreasing
population of cross-bridges with bound Vi.
Increased kTR when force and the fraction of normal
cycling cross-bridges is reduced by Vi can be understood in
the context of a model of cardiac contractile activation
proposed by Campbell (58) and Razomova et al. (59). In this
model the activation dependence of kTR reﬂects not only the
intrinsic kinetics of the acto-myosin interaction, but also
cooperative activation of thin ﬁlaments during recruitment of
strong-binding cross-bridges. This idea is supported by
structural studies indicating that cycling strong cross-bridges
stabilize the ‘‘open’’ thin ﬁlament state (2). The Campbell/
Razumova model suggests that kTR is slowed at submaximal
Ca21 activation because under this condition the available
cross-bridge pool for recruitment is large. As recruitment
proceeds activation by cross-bridges incrementally increases
and the approach to the ﬁnal steady force level is slowed
(58). Steady force at a given [Ca21] is ﬁnally achieved when
strong cross-bridge recruitment is balanced by cross-bridge
transition to weak-binding states. In contrast, at higher
[Ca21] and greater strong cross-bridge binding to thin ﬁla-
ments, the pool of cycling cross-bridges available for re-
cruitment is reduced, along with the subsequent net effect of
any cross-bridge recruitment on thin ﬁlament state. Thus
interventions that reduce the size of the cross-bridge pool
available for recruitment, such as inhibition of cross-bridge
binding by Vi (Fig. 4), should reduce the slowing effect of
cross-bridge recruitment on kTR and thereby cause kTR to
become faster at submaximal Ca21 activation, as we ﬁnd
(Fig. 9). In fact, Fig. 2 A indicates that with maximal force
inhibition at 1.0 mM Vi kTR increased, suggesting that even
at saturating [Ca21] cross-bridge recruitment contributes to
activation of cardiac thin ﬁlaments. This is consistent with
the idea that at saturating [Ca21] cardiac thin ﬁlaments may
not be fully activated (54). Thus the effects of Vi on force
and kTR at all levels of Ca
21 activation (Fig. 9) are consistent
with the Campbell/Razumova model (58,59). The impor-
tance of cross-bridge recruitment in setting the level of thin
ﬁlament activation and the kinetics of force development are
further supported by recent observations that ‘‘stretch activ-
ation’’ in single cardiac myocytes was signiﬁcantly reduced
and force development kinetics elevated when thin ﬁlaments
were activated with NEM-S1 (60).
The authors thank Drs. Franklin Fuchs and Albert M. Gordon for helpful
comments on the manuscript and Mr. Gary Melvin (National Institute of
Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National
Institutes of Health) for his technical and experimental support. We also
thank the staff at beamline X27C at Brookhaven National Laboratories for
their expert help.
This work was supported by NIH HL 67071 (D.A.M.) and NIH HL61683
(M.R.). This research was also supported in part by the Intramural Research
Program of the NIAMS of the National Institutes of Health (L.Y. and S.X.).
REFERENCES
1. Gordon, A. M., E. Homsher, and M. Regnier. 2000. Regulation of
contraction in striated muscle. Physiol. Rev. 80:853–924.
2. Pirani, A., C. Xu, V. Hatch, R. Craig, L. S. Tobacman, and
W. Lehman. 2005. Single particle analysis of relaxed and activated
muscle thin ﬁlaments. J. Mol. Biol. 346:761–772.
3. Lehrer, S. S., andM. A. Geeves. 1998. The muscle thin ﬁlament as a classical
cooperative/allosteric regulatory system. J. Mol. Biol. 277:1081–1089.
4. Geeves, M. A., and K. C. Holmes. 1999. Structural mechanism of
muscle contraction. Annu. Rev. Biochem. 68:687–728.
5. Hofmann, P. A., and F. Fuchs. 1987. Evidence for a force-dependent
component of calcium binding to cardiac troponin C. Am. J. Physiol.
253:C541–C546.
6. Wang, Y. P., and F. Fuchs. 1994. Length, force, and Ca21-troponin C
afﬁnity in cardiac and slow skeletal muscle. Am. J. Physiol. 266:
C1077–C1082.
7. Martyn, D. A., and A. M. Gordon. 2001. Inﬂuence of length on force
and activation-dependent changes in troponin c structure in skinned
cardiac and fast skeletal muscle. Biophys. J. 80:2798–2808.
8. Martyn, D. A., M. Regnier, D. Xu, and A. M. Gordon. 2001. Ca21 and
cross-bridge dependent changes in N- and C-terminal structure of
troponin C in rat cardiac muscle. Biophys. J. 80:360–370.
9. Fuchs, F., and D. A. Martyn. 2005. Length-dependent activation in cardiac
muscle: some remaining questions. J. Musc. Res. Cell Motil. 26:199–212.
10. Martyn, D. A., and L. Smith. 2005. The effects of force inhibition with
sodium vanadate on cross-bridge binding, kinetics, and contractile
activation by Ca21 in cardiac muscle. Biophys. J. 88:121a (Abstr.).
11. Goodno, C. C. 1982. Myosin active-site trapping with vanadate ion.
Methods Enzymol. 85:116–123.
12. Martyn, D. A., and P. B. Chase. 1995. Faster force transient kinetics
at submaximal Ca21 activation of skinned psoas ﬁbers from rabbit.
Biophys. J. 68:235–242.
13. Chase, P. B., D. A. Martyn, and J. D. Hannon. 1994. Activation
dependence and kinetics of force and stiffness inhibition by
4388 Martyn et al.
Biophysical Journal 92(12) 4379–4390
aluminoﬂuoride, a slowly dissociating analogue of inorganic phos-
phate, in chemically skinned ﬁbres from rabbit psoas muscle. J. Musc.
Res. Cell. Motil. 15:119–129.
14. Adhikari, B. B., M. Regnier, A. J. Rivera, K. L. Kreutziger, and D. A.
Martyn. 2004. Cardiac length dependence of force and force redevel-
opment kinetics with altered cross-bridge cycling. Biophys. J. 87:
1784–1794.
15. Xu, S., J. Gu, G. Melvin, and L. C. Yu. 2002. Structural character-
ization of weakly attached cross-bridges in the A.M.ATP state in
permeabilized rabbit psoas ﬁbers. Biophys. J. 82:2111–2122.
16. Martyn, D. A., B. B. Adhikari, M. Regnier, J. Gu, S. Xu, and L. Yu.
2004. Response of equatorial x-ray reﬂections and stiffness to altered
sarcomere length and myoﬁlament lattice spacing in relaxed skinned
cardiac muscle. Biophys. J. 86:1002–1011.
17. Dantzig, J. A., and Y. E. Goldman. 1985. Suppression of muscle
contraction by vanadate. Mechanical and ligand binding studies on
glycerol-extracted rabbit ﬁbers. J. Gen. Physiol. 86:305–327.
18. Chase, P. B., D. A. Martyn, M. J. Kushmerick, and A. M. Gordon.
1993. Effects of inorganic phosphate analogues on stiffness and
unloaded shortening of skinned muscle ﬁbres from rabbit. J. Physiol.
(Lond.). 460:231–246.
19. Strauss, J. D., C. Zeugner, J. E. Van Eyk, C. Bletz, M. Troschka, and
J. C. Ru¨egg. 1992. Troponin I replacement in permeabilized cardiac
muscle. Reversible extraction of troponin I by extraction with vanadate.
FEBS Lett. 310:229–234.
20. Brenner, B. 1986. The cross-bridge cycle in muscle. Mechanical,
biochemical, and structural studies on single skinned rabbit psoas ﬁbers
to characterize cross-bridge kinetics in muscle for correlation with the
actomyosin-ATPase in solution. Bas. Res. Cardiol. 81:1–15.
21. Brenner, B., M. Schoenberg, J. M. Chalovich, L. E. Greene, and E.
Eisenberg. 1982. Evidence for cross-bridge attachment in relaxed
muscle at low ionic strength. Proc. Natl. Acad. Sci. USA. 79:7288–
7291.
22. Brenner, B., S. Xu, J. Chalovich, and L. C. Yu. 1996. Radial
equilibrium lengths of actomyosin cross-bridges in muscle. Biophys.
J. 71:2751–2758.
23. Brenner, B., and L. C. Yu. 1985. Equatorial x-ray diffraction from
single skinned rabbit psoas ﬁbers at various degrees of activation.
Changes in intensities and lattice spacing. Biophys. J. 48:829–834.
24. Takemori, S., M. Yamagichi, and N. Yagi. 1995. An x-ray diffraction
study on a single frog skinned muscle ﬁber in the presence of vanadate.
J. Biochem. (Tokyo). 117:603–608.
25. Dantzig, J. A., M. G. Hibberd, D. R. Trentham, and Y. E. Goldman.
1991. Cross-bridge kinetics in the presence of MgADP investigated by
photolysis of caged ATP in rabbit psoas muscle ﬁbres. J. Physiol.
(Lond.). 432:639–680.
26. Cooke, R., and E. Pate. 1985. The effects of ADP and phosphate on the
contraction of muscle ﬁbers. Biophys. J. 48:789–798.
27. Regnier, M., C. Morris, and E. Homsher. 1995. Regulation of the
cross-bridge transition from a weakly to strongly bound state in
skinned rabbit muscle ﬁbers. Am. J. Physiol. 269:C1532–C1539.
28. Araujo, A., and J. W. Walker. 1996. Phosphate release and force
generation in cardiac myocytes investigated with caged phosphate and
caged calcium. Biophys. J. 70:2316–2326.
29. Hinken, A. C., and K. S. McDonald. 2006. Beta-myosin heavy chain
myocyctes are more resistant to changes in power output induced by
ischemic conditions. Am. J. Physiol. (Heart). 290:H869–H877.
30. Kawai, M., and H. R. Halvorson. 1989. Role of MgATP and MgADP
in the cross-bridge kinetics in chemically skinned rabbit psoas ﬁbers.
Study of a fast exponential process (C). Biophys. J. 55:595–603.
31. Lu, Z., R. L. Moss, and J. W. Walker. 1993. Tension transients initiated
by photogeneration of MgADP in skinned skeletal muscle ﬁbers.
J. Gen. Physiol. 101:867–888.
32. Schoenberg, M., and E. Eisenberg. 1987. ADP binding to myosin
cross-bridges and its effect on the cross-bridge detachment rate con-
stants. J. Gen. Physiol. 89:905–920.
33. Regnier, M., D. A. Martyn, and P. B. Chase. 1998. Calcium regulation
of tension redevelopment kinetics with 2-deoxy-ATP or low [ATP] in
rabbit skeletal muscle. Biophys. J. 74:2005–2015.
34. Dantzig, J. A., M. G. Hibberd, Y. E. Goldman, and D. R. Trentham.
1984. ADP slows cross-bridge detachment rate induced by photo-
lysis of caged ATP in rabbit psoas muscle ﬁbers. Biophys. J. 45:8a
(Abstr.).
35. Chase, P. B., and M. J. Kushmerick. 1995. Effect of physiological
ADP levels on contraction of single skinned ﬁbers from rabbit fast and
slow muscles. Am. J. Physiol. 268:C480–C489.
36. Ferenczi, M. A., Y. E. Goldman, and R. M. Simmons. 1984. The
dependence of force and shortening velocity on substrate concentra-
tion in skinned muscle ﬁbres from Rana temporaria. J. Physiol. 350:
519–543.
37. Goodno, C. C., and E. W. Taylor. 1982. Inhibition of actomyosin
ATPase by vanadate. Proc. Natl. Acad. Sci. USA. 79:21–25.
38. Smith, C. A., and I. Rayment. 1995. X-ray structure of the mag-
nesium(II)ADPvanadate complex of the Dictyostelium discoideum
myosin motor domain to 1.9 A˚ resolution. Biochem. 35:5404–
5417.
39. Xu, S., G. Offer, H. D. White, and L. C. Yu. 2003. Temperature and
ligand dependence of conformation and helical order in myosin
ﬁlaments. Biochem. 42:390–401.
40. Holmes, K. C., and M. A. Geeves. 2000. The structural basis of muscle
contraction. Philos. Trans. R. Soc. Lond. B. 355:419–431.
41. Houdusse, A., and H. L. Sweeney. 2001. Myosin motors: missing
structures and hidden springs. Curr. Opin. Struct. Biol. 11:182–194.
42. Webb, M. R., M. G. Hibberd, Y. E. Goldman, and D. R. Trentham.
1986. Oxygen exchange between Pi in the medium and water during
ATP hydrolysis mediated by skinned ﬁbers from rabbit skeletal muscle:
evidence for Pi binding to a force-generating state. J. Biol. Chem.
261:15557–15564.
43. Martyn, D. A., P. B. Chase, M. Regnier, and A. M. Gordon. 2002.
A simple model with myoﬁlament compliance predicts activation-
dependent cross-bridge kinetics in skinned skeletal ﬁbers. Biophys. J.
83:3425–3434.
44. Luo, Y., R. Cooke, and E. Pate. 1994. Effect of series elasticity on
delay in development of tension relative to stiffness during muscle
activation. Am. J. Physiol. 267:C1598–C1606.
45. Schoenberg, M. 1985. Equilibrium muscle cross-bridge behavior:
theoretical considerations. Biophys. J. 48:467–475.
46. Schoenberg, M. 1988. The kinetics of weakly- and strongly-binding
crossbridges: Implications for contraction and relaxation. In Molecular
Mechanism of Muscle Contraction. H. Sugi and G. H. Pollack, editors.
Plenum Publishing, New York. 189–200.
47. Schoenberg, M. 1988. Characterization of the myosin adenosine tri-
phosphate (M.ATP) crossbridge in rabbit and frog skeletal muscle ﬁbers.
Biophys. J. 54:135–148.
48. Dantzig, J. A., Y. E. Goldman, N. C. Millar, J. Lacktis, and
E. Homsher. 1992. Reversal of the cross-bridge force-generating
transition by photogeneration of phosphate in rabbit psoas muscle
ﬁbres. J. Physiol. 451:247–278.
49. Brenner, B., L. C. Yu, and J. M. Chalovich. 1991. Parallel inhibition of
active force and relaxed ﬁber stiffness in skeletal muscle by caldesmon:
implications for the pathway to force generation. Proc. Natl. Acad. Sci.
USA. 88:5739–5743.
50. Pate, E., and R. Cooke. 1989. Addition of phosphate to active muscle
ﬁbers probes actomyosin states within the powerstroke. Pﬂugers Arch.
414:73–81.
51. Herzig, J. W., J. W. Peterson, J. C. Ru¨egg, and R. J. Solaro. 1981.
Vanadate and phosphate ions reduce tension and increase cross-bridge
kinetics in chemically skinned heart muscle. Biochim. Biophys. Acta.
672:191–196.
52. Brenner, B. 1988. Effect of Ca21 on cross-bridge turnover kinetics in
skinned single rabbit psoas ﬁbers: implications for regulation of muscle
contraction. Proc. Natl. Acad. Sci. USA. 85:3265–3269.
Force Inhibition with Vanadate Increases kTR 4389
Biophysical Journal 92(12) 4379–4390
53. Metzger, J. M., and R. L. Moss. 1990. Calcium-sensitive cross-bridge
transitions in mammalian fast and slow skeletal muscle ﬁbers. Science.
247:1088–1090.
54. Regnier, M., H. Martin, R. J. Barsotti, D. A. Martyn, and E. W.
Clemmens. 2004. Crossbridge vs. thin ﬁlament contributions to the level
and rate of force development in cardiac muscle. Biophys. J. 87:1815–
1824.
55. Fitzsimmons, D. P., J. R. Patel, and R. L. Moss. 2001. Cross-bridge
interaction kinetics in rat myocardium are accelerated by strong
binding of myosin to the thin ﬁlament. J. Physiol. 530:263–272.
56. Warner-Clemmens, E., M. Entazari, D. A. Martyn, and M. Regnier.
2005. Different effects of cardiac vs. skeletal muscle regulatory pro-
teins on in vitro measures of actin ﬁlament speed and force. J. Physiol.
566:737–746.
57. Moreno-Gonzalez, A., T.E. Gillis, A.J. Rivera, P.B. Chase, D.A.
Martyn, and M. Regnier. 2007. Thin ﬁlament regulation of force
redevelopment kinetics in rabbit skeletal muscle ﬁbres. J. Physiol.
579:313–326.
58. Campbell, K. 1997. Rate constant of muscle force redevelopment
reﬂects cooperative activation as well as cross-bridge kinetics. Biophys.
J. 72:254–262.
59. Razumova, M. V., A. E. Bukatina, and K. B. Campbell. 2000.
Different myoﬁlament nearest-neighbor interactions have distinctive
effects on contractile behavior. Biophys. J. 78:3120–3137.
60. Stelzer, J. E., L. Larsson, D. P. Fitzsimmons, and R. L. Moss. 2006.
Activation dependence of stretch activation in mouse skinned myo-
cardium: implications for ventricular function. J. Gen. Physiol. 127:
95–107.
4390 Martyn et al.
Biophysical Journal 92(12) 4379–4390
